Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock ,,, Gel-Heavy
Phase Lock Gel may ... IMPORTANT: When working with TRIzol Reagent use appropriate pr...
Phase Lock Gel may be used in conjunction with TRIzol Reagent for the
isolation of total RNA from cell and tissue samples. Increased yields are
observed using this method, because the entire aqueous phase can be recovered
without interphase contamination. Below is a protocol outlining the steps
involved in RNA isolation with TRIzol Reagent and Phase Lock Gel-Heavy.
For further details about TRIzol Reagent, please refer to TRIzol Reagent
protocol.
IMPORTANT: When working with TRIzol Reagent, use appropriate protective
clothing and work under a chemical fume hood.
- Homogenization:
- Tissues: Add 1 ml TRIzol Reagent per 50100 mg tissue and
homogenize with a POLYTRON homogenizer. For 110 mg quantities
of tissue, add 0.8 ml TRIzol Reagent and 0.2 ml 1 mg/ml mussel glycogen
and homogenize.
- Cells grown in a Monolayer: Lyse cells by adding 1 ml TRIzol Reagent
per 10 cm2 area of culture dish. Pipette suspension several times
to disrupt cells. For 102104 cells, add 0.8 ml TRIzol Reagent
and 0.2 ml 1 mg/ml mussel glycogen and homogenize.
- Cells grown in Suspension: Pellet cells by centrifugation. Do
not wash cell pellet. Add 1 ml TRIzol Reagent per 510 x 106
animal, plant, or yeast cells or 1 x 107 bacterial cells. Resuspend
pellet by pipetting to lyse cells. For 102104 cells, add 0.8
ml TRIzol Reagent and 0.2 ml 1 mg/ml mussel glycogen and homogenize.
- Pre-spin the appropriate sized Phase Lock Gel-Heavy tubes briefly
to collect gel on tube bottoms (1500 x g for 30 seconds is sufficient
to collect gel at tube bottoms).
- Add cell lysate to the tubes containing pre-spun Phase Lock Gel-Heavy
and incubate 5 minutes at 1530C.
- Add 0.2 ml chloroform (or chloroform-isoamyl alcohol) per 1 ml TRIzol
Reagent initially used. Cap tubes and shake vigorously for 15 seconds.
DO NOT VORTEX!
- Centrifuge samples at no more than 12,000 x g for 10 minutes at 28C.
NOTE: 15 ml and 50 ml PLG-H screw-cap tubes should be centrifuged
at or below 2000 x g.
- Examine phasing. Clear, aqueous phase should be entirely atop Phase
Lock Gel. The phenol-chloroform phase and cloudy interphase should be
below Phase Lock Gel layer. If this is not the case, add another 0.2
ml chloroform (or chloroform-isoamyl alcohol) per 1 ml TRIzol Reagent
used initally and shake vigorously. Repeat centrifugation and re-examine
phasing.
- Transfer aqueous phase containing RNA to a fresh tube (aqueous phase
may be decanted).
- Precipitate RNA by adding 0.5 ml Isopropyl alcohol per 1 ml TRIzol
Reagent used initially. Mix samples by repeated inversion. Allow samples
to incubate at 1530C for 10 minutes. Centrifuge samples for
10 minutes at no more than 12,000 x g, 28C. RNA pellet should
be visible on side and bottom of tube.
- Decant supernatant. Add 1 ml 75% ethanol per 1 ml TRIzol Reagent used
initially to wash the RNA pellet. Mix samples to dislodge pellet, using
a vortex if necessary. Centrifuge samples at no more than 7,500 x g
for 5 minutes at 28C.
- Carefully decant supernatant. Briefly air-dry or vacuum-dry the RNA
pellet to remove residual ethanol (510 minutes). Do not overdry
pellet by centrifugation under vacuum as this will make resuspension
more difficult. Dissolve RNA pellet in Molecular Biology Grade water,
incubating at 5560C for 10 minutes to facilitate dissolution.
'"/>Source:
Page: All 1 2 3 Related biology technology :1.
New Protocols for Isolating High- Molecular-Weight Genomic DNA2.
Eppendorf Multiporator Transfection Protocols for Eukaryotic
Cells3.
Lambda DNA Extraction Protocol4.
M13/Phagemid DNA Extraction Protocol5.
Mouse Tail Genomic DNA Isolation Protocol(1)6.
Genomic DNA Isolation Protocol(1,2,3)7.
Basic Plasmid DNA Isolation Protocol8.
Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock
Gel-Heavy9.
RNA-free Plasmid DNA Isolation Protocol10.
Lambda DNA Extraction Protocol11.
Eppendorf Multiporator Transfection Protocols for Eukaryotic
Cells
(Date:11/21/2008)...Call/ -- BioMarin Pharmaceutical,Inc. (Nasdaq: ...hief Medical,Officer will retire from the company... leave his position with the company to allow him ... endeavors related to rare diseases. Dr.,Kakkis ...or the foreseeable,future. , "I am extreme...
(Date:11/21/2008)...Call/ -- CorVel Corporation,(Nasdaq: CRVL ) ann...er the new,Medicare legislation requiring expande...ors and employers. The Company currently provides...ompensation and general liability,customers throu...ffering to,include communications soon to be mand...
(Date:11/21/2008)...e Center is First Integrated Knowledge Center Outs...Hyderabad, India (Vocus) November 21, 2008 -&ndash...today, 17 months after breaking ground last summer... in the city’s Genome Valley, the center wil... region in the areas of agricultural and industria...
(Date:11/21/2008)...UCTURING ALTERNATIVES ONGOING , , VANCOUVER...aceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a gl...ompany, today announced that the Company had been ...nture Partners (New Leaf) that they had elected to...7, 2008. Angiotech had announced on September 22, ...
Breaking Biology Technology:BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 2BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 3BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 4CorVel Announces MSA Agent Services 2CorVel Announces MSA Agent Services 3DuPont Opens Research & Development Center in India 2DuPont Opens Research & Development Center in India 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4... Stratagenes custom molecular beacon synthesis a... , Fei Bao , University of Colorad... We used Stratagenes custom molecular beacons ff,...NP) in a region of chromosome,10q25.1 and showed...s carried in,family members. This molecular beac...
...,,,, Culture 192 clones simul...ff Braman ,Stratagene , , , F... , The tempest thermoshaker and a 96-deep-w...ate bacterial clones in a, high-throughput ...l growth, were equivalent in aerated and no...
...,, Many different tissue types on a con...as ,Stratagene , Stratagenes Complete View t...issue array technology through optimized,tissue ...issue morphology,antigenicity of proteins, and ...,line consists of murine (male and female) survey ...
... Produce large quantities of difficult-to-express...rd Becker ,Biochemical & Molecular Allergology, ...tagenes BL21-CodonPlus(DE3)-RIL cells * with,ext...nes,it is possible to attain high-level express... usage: IPTG-induced expression of several recombi...
Other Biology Technology:Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 2Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 3Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 4Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 5Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 6High-Throughput Cultivation of Bacterial Clones 2High-Throughput Cultivation of Bacterial Clones 3Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 2Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 3Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 4Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 5High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4...f Medicine researchers have discovered how new neu...nt to regions of the brain where they can replace ...tem cell therapies can be specifically targeted to...ses or by stroke. , Associate Professor Qun-Yong Z...artment of Pharmacology have identified a protein ...
... the world are breathing a sigh of relief, as they...ir natural disease-fighting substances. Scientists... didemnii, which lives symbiotically inside the se...es, compounds that may one day be used in cancer t...s could not successfully cultivate Prochloron in t...
...sma protein found in blood, can be fused with larg...stimulating factor (G-CSF) to create a new oral co...rough the gastrointestinal (GI) tract and then abl... the body, according to research from the Universi...is technology may allow for oral administration of...
...factors prove that BioMed Central,s Open Access jo... Journals published by BioMed Central have again r...valent subscription titles, it was announced today...lty. The high impact factors for these journals af...re fast becoming the place for authors to submit i...
Other Biology News:Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 3'Bionic' arm gives amputee sense of touch 2Protein Marker Detection Pack contains biotinylate
JMJD2B Antibody
Agarose, Biotechnology grade, 500g
...to-oncogene was first identified as the cellular h...Jun B and Jun D have been shown to be almost ident...re involved in dimerization and DNA binding, where... transcriptional activation, diverge. Antigen: ...
Biology Products: